Radioimmunoassay for plasma C-type natriuretic peptide determination: A methodological evaluation

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 6, 2005, Pages 641-645

  Del Ry, Silvia ^a   Maltinti, Maristella ^a   Emdin, Michele ^a   Passino, Claudio ^a   Catapano, Giosué ^a   Giannessi, Daniela ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

C type natriuretic peptide (CNP); Chronic heart failure (CHF); Hepatic cirrhosis; Natriuretic peptide; Radioimmunoassay (RIA)

Indexed keywords

NATRIURETIC PEPTIDE TYPE C;

ACCURACY; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CROSS REACTION; DILUTION; ENDOTHELIUM LESION; FEMALE; HEART FAILURE; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RADIOIMMUNOASSAY; RELIABILITY; SENSITIVITY ANALYSIS; BLOOD; CONGESTIVE HEART FAILURE; EVALUATION; FIBROSIS; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SPECIES DIFFERENCE; STANDARD; TECHNIQUE;

AGED; CROSS REACTIONS; FEMALE; FIBROSIS; HEART FAILURE, CONGESTIVE; HUMANS; MALE; METHODS; MIDDLE AGED; NATRIURETIC PEPTIDE, C-TYPE; RADIOIMMUNOASSAY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

EID: 26044461919     PISSN: 14346621     EISSN: 14346621     Source Type: Journal    
DOI: 10.1515/CCLM.2005.110     Document Type: Article

References (18)

1. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-Type natriuretic peptide (CNP): a new member of the natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun 1990;168:863-70.
2. Barr CS, Rhodes P, Struthers AD. C-Type natriuretic peptide. Peptides 1996;17:1243-51.
3. Kalra PR, Anker SD, Struthers AD, Coats AJS. The role of C-type natriuretic peptide in cardiovascular medicine. Eur Heart J 2001;22:997-1007.
4. D'Souza SP, Davis M, Baxter GF. Autocrine and paracrine actions of natriuretic peptides in the heart. Pharmacol Ther 2004;101:113-29.
5. Baxter GF. The natriuretic peptides. Basic Res Cardiol 2004;99:71-5.
6. Del Ry S, Passino C, Maltinti M, Emdin M, Giannessi D. C-Type natriuretic peptide plasma levels increase in patients with chronic heart failure as a function of clinical severity. Eur J Heart Fail (in press).
7. Wei CM, Heublein DM, Perella MA, Lerman A, Rodeheffer RJ, McGregor CG, et al. Natriuretic peptide system in human heart failure. Circulation 1993;88:1004-9.
8. Totsune K, Takahashi K, Murakami O, Satoh F, Sone M, Mouri T. Elevated plasma C-type natriuretic peptide concentrations in patients with chronic renal failure. Clin Sci 1994;87:319-22.
9. Cargill RI, Barr CS, Coutie WJ, Struthers AD, Lipworth BJ. C-Type natriuretic peptide levels in cor pulmonale and in congestive cardiac failure. Thorax 1994; 49:1247-9.
10. Prickett TC, Yandle TG, Nicholls MG, Espiner EA, Richards AM. Identification of amino-terminal pro-C-type natriuretic peptide in human plasma. Biochem Biophys Res Commun 2001;286:513-7.
11. Kalra PR, Clague JR, Bolger AP, Anker SD, Poole-Wilson PA, Struthers AD, et al. Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation 2003;107:571-3.
12. Wright SP, Prickett TC, Doughty RN, Frampton C, Gamble GD, Yandle TG, et al. Amino-terminal pro-C-type natriuretic peptide in heart failure. Hypertension 2004; 43:94-100.
13. Potter LR. CNP, cardiac natriuretic peptide? Endocrinology 2004;145:2129-30.
14. Gulberg V, Moller S, Henriksen JH, Gerbes AL. Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure. Gut 2000;47:852-7.
15. Pilo A, Zucchelli GC, Malvano R, Masini S. Main features of computer algorithms for RIA data reduction. Comparison of same different approaches for the interpolation of dose-response curve. J Nucl Med Allied Sci 1982; 26:235-48.
16. Andreassi MG, Del Ry S, Palmieri C, Clerico A, Biagini A, Giannessi D. Up-regulation of "clearance" receptors in patients with chronic heart failure: a possible explanation for the resistance to biological effects of cardiac natriuretic hormones. Eur J Heart Fail 2001;3:407-14.
17. Bauersachs J, Schafer A. Endothelial dysfunction in heart failure: mechanism and therapeutic approaches. Curr Vasc Pharmacol 2004;2:115-24.
18. Cahill PA, Redmound EM, Sitzmann JV. Endothelial dysfunction in cirrhosis and portal hypertension. Pharmacol Ther 2001;89:273-93.